Colgate-Palmolive (NYSE:CL) CMO Mukul Deoras sold 2,572 shares of Colgate-Palmolive stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $70.19, for a total value of $180,528.68. Following the completion of the sale, the chief marketing officer now owns 39,825 shares of the company’s stock, valued at $2,795,316.75. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.
Mukul Deoras also recently made the following trade(s):
- On Monday, February 12th, Mukul Deoras sold 7,150 shares of Colgate-Palmolive stock. The stock was sold at an average price of $70.03, for a total value of $500,714.50.
Colgate-Palmolive (CL) opened at $70.30 on Friday. Colgate-Palmolive has a 12-month low of $68.19 and a 12-month high of $77.91. The company has a debt-to-equity ratio of 27.02, a quick ratio of 1.00 and a current ratio of 1.36. The firm has a market capitalization of $60,738.92, a PE ratio of 30.83, a PEG ratio of 2.57 and a beta of 0.75.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 26th. The company reported $0.75 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.75. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The firm had revenue of $3.89 billion for the quarter, compared to analysts’ expectations of $3.92 billion. During the same period in the previous year, the firm earned $0.75 EPS. The business’s quarterly revenue was up 4.6% on a year-over-year basis. sell-side analysts predict that Colgate-Palmolive will post 3.18 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Thursday, February 15th. Stockholders of record on Tuesday, January 23rd were given a dividend of $0.40 per share. The ex-dividend date of this dividend was Monday, January 22nd. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.28%. Colgate-Palmolive’s payout ratio is currently 70.18%.
Several hedge funds have recently bought and sold shares of CL. Jacobi Capital Management LLC lifted its holdings in Colgate-Palmolive by 125.5% in the 3rd quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock worth $104,000 after purchasing an additional 803 shares in the last quarter. Virtue Capital Management LLC purchased a new position in Colgate-Palmolive in the 4th quarter worth approximately $104,000. Krilogy Financial LLC lifted its holdings in Colgate-Palmolive by 23.0% in the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after purchasing an additional 289 shares in the last quarter. Captrust Financial Advisors purchased a new position in Colgate-Palmolive in the 2nd quarter worth approximately $122,000. Finally, AlphaMark Advisors LLC lifted its holdings in Colgate-Palmolive by 1.5% in the 2nd quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock worth $126,000 after purchasing an additional 25 shares in the last quarter. 71.52% of the stock is currently owned by hedge funds and other institutional investors.
Several equities research analysts recently commented on the company. Jefferies Group reiterated a “hold” rating and issued a $79.00 price objective on shares of Colgate-Palmolive in a report on Friday, January 26th. Societe Generale downgraded Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 price target for the company. in a research note on Wednesday, November 29th. They noted that the move was a valuation call. Zacks Investment Research downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Friday, January 5th. Citigroup cut their price target on Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating for the company in a research note on Thursday, November 2nd. Finally, Stifel Nicolaus set a $73.00 price target on Colgate-Palmolive and gave the company a “hold” rating in a research note on Sunday, October 29th. Three investment analysts have rated the stock with a sell rating, ten have given a hold rating and five have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $77.91.
TRADEMARK VIOLATION NOTICE: “Colgate-Palmolive (CL) CMO Mukul Deoras Sells 2,572 Shares” was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of US & international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/02/24/colgate-palmolive-cl-cmo-mukul-deoras-sells-2572-shares.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.